查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1901499

临床前生物分析检测服务市场：依工作流程、分子、检测项目、最终用途、国家及地区划分－全球产业分析、市场规模、市场占有率及2025-2032年预测

Preclinical Bioanalytical Testing Services Market, By Workflow, By Molecule, By Test, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 355 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年临床前生物分析测试服务市场规模为 12.3456 亿美元，从 2025 年到 2032 年以 9.5% 的复合年增长率成长。

临床前生物分析检测服务市场是一个合约研究和实验室服务领域，透过在临床试验前分析候选药物的药物动力学 (PK)、毒理学、生物标记和生物利用度来支持药物开发。这些服务提供可靠、合规且数据驱动的分子安全性和有效性评估。生物製剂和复杂疗法数量的不断增长需要先进的分析平台，这推动了市场成长。一个重要的趋势是，高灵敏度液相层析-串联质谱 (LC-MS/MS) 和自动化技术的日益普及，提高了检测通量和资料准确性。然而，该市场也面临着许多挑战，例如高昂的营运成本和严格的监管要求，这些都会延长检测週期。儘管有这些挑战，製药和生技公司外包业务的扩张，尤其是在特殊检测和方法开发方面，代表着巨大的机会，使得临床前生物分析服务成为现代药物发现流程中不可或缺的组成部分。

临床前生物分析检测服务市场—市场动态

慢性病盛行率上升推动市场成长

慢性病盛行率的上升预计将推动临床前生物分析检测服务市场的未来成长。慢性病是指持续三个月或更长时间且病情可能随时间恶化的疾病。生物分析检测服务有助于识别和测量与慢性病相关的特定生物标记物，以及进行治疗药物监测，确保患者体内的药物浓度保持在治疗范围内。例如，根据美国国家医学图书馆（一家总部位于美国的机构）的数据显示，到2050年，美国50岁及以上患有至少一种慢性病的人口数量将增加99.5%，即1.4266亿。此外，总部位于瑞士的政府间卫生组织－世界卫生组织（WHO）在2022年报告中指出，2022年9月全球共有4,100万人死于非传染性疾病（NCD）或慢性病，占全球所有非传染性疾病死亡人数的74%。因此，慢性病盛行率的上升推动了临床前生物分析测试服务产业的扩张。

临床前生物分析检测服务市场細項分析：

全球临床前生物分析测试服务市场按工作流程、分子、测试、最终用途和地区进行细分。

根据测试结果，生物利用度测试将成为生物分析检测服务市场中最重要的细分领域。生物利用度对于确定新药在临床试验给药后的药物动力学特征至关重要。此外，目前正在进行的临床试验数量也不断增加。因此，将生物利用度测试纳入这些试验对于确保所用製剂的一致性和稳定性至关重要，最终有助于改善患者的治疗效果。例如，根据世界卫生组织国际临床试验註册平台（ICTRP）于2023年2月发布的报告，2022年西太平洋地区的临床试验註册数量显着增加。这一增长主要归功于中国和日本大量的临床试验註册，两国分别位列该地区第一和第二。

依工作流程划分，样品采集和製备领域凭藉其选择性、便利性、速度和萃取阶段配置等优势，占据了市场主导地位。为满足日益增长的自动化、减少溶剂用量和小型化需求，技术驱动的样品製备方法正在不断发展，从而实现现场、原位和体内应用。例如，2023年11月，赛默飞世尔科技推出了体外诊断 (IVD) 和体外诊断法规 (IVD-R) 认证实验室的自动化样品製备解决方案。这些新解决方案将有助于改进和自动化呼吸系统诊断检测。

临床前生物分析检测服务市场—地域洞察

北美凭藉其创新精神和完善的基础设施，在临床前生物分析检测服务市场中脱颖而出。该地区拥有成熟且完善的设施。尤其值得一提的是，美国拥有庞大的製药和生技产业，因此对生物分析检测服务的需求十分旺盛。此外，该地区严格的FDA监管确保製药公司维持高标准的检测质量，这也使得生物分析检测服务不可或缺。因此，各大公司正在拓展其检测服务组合，以满足不断成长的需求。 2024年8月，SGS Societe Generale de Surveillance SA在Agilex Biolabs Pty Ltd的协助下，在北美推出了全新的生物分析检测服务。此次业务拓展扩大了检测解决方案的范围，并透过为临床试验和药物研发提供全面支持，促进了市场成长。

美国临床前生物分析检测服务市场—国家概况

由于对精准医疗的需求不断增长，以及生物製剂和生物相似药研发管线的不断扩充，美国市场正迅速扩张。根据产业报告显示，截至2024年12月，美国已有64种生物相似药获批上市，凸显了美国在生物製剂创新领域的领先地位，以及由此带来的对生物分析验证的庞大需求。药物研发中药物动力学和药效学研究的重要性日益凸显，也增加了专业分析方法的需求。此外，生命科学研究经费的增加以及对监管合规性的严格要求，促使生物分析检测外包，以确保资料品质的一致性。在分析工作流程中应用高通量筛选和液相层析串联质谱（LC-MS/MS）等尖端技术，能够提高结果的准确性并缩短週转时间。

目录

第一章：临床前生物分析检测服务市场概述

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：临床前生物分析检测服务主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：临床前生物分析测试服务产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：临床前生物分析检测服务市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：临床前生物分析检测服务市场概况

  • 2024年临床前生物分析检测服务市占率分析
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：临床前生物分析测试服务市场：依工作流程划分

  • 概述
    • 细分市场占有率分析：依工作流程
    • 样品分析
      • 连字符技术
      • 色谱技术
      • 电泳
      • 配体结合试验
      • 质谱分析
      • 光谱技术
      • 基因组学和分子技术
    • 方法开发与验证
    • 样本采集与製备
      • 样本采集、处理和储存
      • 蛋白质沉淀
      • 液态萃取
      • 固相萃取
      • 其他的
    • 其他流程

第八章：临床前生物分析测试服务市场：依分子分类

  • 概述
    • 细分市占率分析：按分子
    • 小分子
    • 大分子

第九章：临床前生物分析检测服务市场：依检测方式划分

  • 概述
    • 细分市场占有率分析：按测试
    • 生物利用度
    • 生物等效性
    • 生物标记检测
    • ADME
      • 体内
      • 体外
    • 药物动力学（PK）
    • 药效学（PD）
    • 基于细胞的检测
    • 病毒学检测
    • 其他测试

第十章：临床前生物分析测试服务市场：依最终用途划分

  • 概述
    • 细分市占率分析：按分子
    • CDMO
    • 信用评等机构
    • 製药和生物製药公司
    • 其他的

第十一章：临床前生物分析检测服务市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十二章：主要供应商分析：临床前生物分析检测服务业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Charles River Laboratories International
    • Syneos Health
    • SGS SA
    • WuXi AppTec
    • Thermo Fisher Scientific Inc (PPD, Inc.)
    • Parexel International
    • Pharmaron
    • BioAgilytix Labs
    • KCAS Bio
    • ICON plc
    • Labcorp
    • Eurofins Scientific SE
    • QPS Holdings
    • Altasciences
    • Others

第十三章：360度AnalystView

简介目录
Product Code: ANV5825

Preclinical Bioanalytical Testing Services Market size was valued at US$ 1,234.56 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Preclinical Bioanalytical Testing Services Market is a contract research and laboratory services segment that supports drug development by analyzing drug candidates' pharmacokinetics (PK), toxicology, biomarkers, and bioavailability prior to clinical trials. These services provide a reliable, compliant, and data-driven assessment of a molecule's safety and efficacy. The increasing number of biologics and complex modalities that require advanced analytical platforms is driving market growth. An important trend is the growing use of high-sensitivity LC-MS/MS and automation to improve throughput and data accuracy. However, the market faces constraints such as high operational costs and stringent regulatory expectations, which lengthen testing timelines. Despite these challenges, the expansion of outsourcing by pharmaceutical and biotechnology companies, particularly for specialty assays and method development, represents a significant opportunity, making preclinical bioanalytical services an essential component of modern drug discovery pipelines.

Preclinical Bioanalytical Testing Services Market- Market Dynamics

Increasing Prevalence of Chronic Diseases Propel Growth In The Market

The rising prevalence of chronic diseases is expected to drive future growth in the preclinical bioanalytical testing services market. Chronic disease is a type of illness that lasts three months or longer and can deteriorate over time. Bioanalytical testing services assist in identifying and measuring specific biomarkers associated with chronic diseases, as well as therapeutic drug monitoring, ensuring that drug levels in the patient's body remain within the therapeutic range. For instance, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition will rise by 99.5%, or 142.66 million, by 2050. Furthermore, the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, reported 41 million deaths in September 2022, accounting for 74% of all deaths caused by noncommunicable diseases (NCDs) or chronic diseases worldwide. As a result, the rising prevalence of chronic diseases fuels the expansion of the Preclinical bioanalytical testing services industry.

Preclinical Bioanalytical Testing Services Market- Segmentation Analysis:

The Global Preclinical Bioanalytical Testing Services Market is segmented by Workflow, Molecule, Test, End Use and Region.

According to the test, the bioavailability test segment will be the most important in the market for bioanalytical testing services. Bioavailability is critical in determining the efficacy of a new drug's pharmacokinetic profile after administration in clinical trials. Furthermore, there has been an increase in the number of active clinical trials. As a result, incorporating bioavailability testing into these trials is critical to ensuring consistency and stability among formulations used, ultimately improving patient outcomes. For instance, according to a report published in February 2023 by the WHO International Clinical Trials Registry Platform (ICTRP), clinical trial registrations in the Western Pacific region increased significantly in 2022. This increase is primarily due to the large number of clinical trial registrations in China and Japan, which rank first and second in the region, respectively.

By Workflow, the Sample Collection and Preparation segment takes over the market due to its selectivity, convenience, speed, and extraction phase configurations. Technology-driven sample preparations are being developed to meet the growing demand for automation, reduced solvent usage, and miniaturization, resulting in on-site, in situ, and in vivo applications. For example, in November 2023, Thermo Fisher Scientific introduced automated sample preparation solutions for laboratories certified for in vitro diagnostics (IVD) and in vitro diagnostic regulation (IVD-R). The new solutions will help to improve and automate respiratory diagnostic testing.

Preclinical Bioanalytical Testing Services Market- Geographical Insights

North America stands out in the preclinical bioanalytical testing services market due to its innovative spirit and robust infrastructure. The region boasts well-established and developed facilities. The United States, in particular, has a high demand for bioanalytical testing services due to its large pharmaceutical and biotechnology industries. Furthermore, strict FDA regulations in the region ensure that pharmaceutical companies maintain high-quality testing standards, necessitating bioanalytical testing services. As a result, major companies are expanding their testing service portfolios to meet rising demand. In August 2024, SGS Societe Generale de Surveillance SA launched its new bioanalytical testing services in North America with the help of Agilex Biolabs Pty Ltd. This expansion expands testing solutions and boosts market growth by offering comprehensive support for clinical trials and drug development.

United States Preclinical Bioanalytical Testing Services Market- Country Insights

The US market is rapidly expanding, owing to increased demand for precision medicine and an expanding pipeline of biologics and biosimilars. According to industry reports, the United States had 64 approved biosimilars as of December 2024, demonstrating the country's leadership in biologics innovation and the resulting demand for bioanalytical validation. The growing importance of pharmacokinetic and pharmacodynamic studies in drug development has increased the demand for specialized analytical methods. Furthermore, increased funding for life sciences research and a strong emphasis on regulatory compliance have prompted the outsourcing of bioanalytical testing to ensure consistent data quality. The application of cutting-edge technologies in analytical workflows, such as high-throughput screening and LC-MS/MS, improves result accuracy and turnaround time.

Preclinical Bioanalytical Testing Services Market- Competitive Landscape:

The preclinical bioanalytical testing services market has a competitive landscape that includes a large number of players, ranging from established companies to emerging startups. The market is highly fragmented, with key players prioritizing strategic collaborations, mergers and acquisitions, and technological advancements to strengthen their market positions. The growing demand for specialized bioanalytical services, fueled by advances in pharmaceutical and biotechnology research, has increased competition, prompting businesses to broaden their service offerings and geographic reach. The emphasis on quality, dependability, and regulatory compliance remains a critical differentiator in this competitive environment. Major companies in the bioanalytical testing services market include Thermo Fisher Scientific Inc (PPD, Inc.), Parexel International, Pharmaron, and BioAgilytix Labs. These companies have established themselves as industry leaders, providing a wide range of bioanalytical services to pharmaceutical and biotechnology companies.

Recent Developments:

In June 2024, Lebanon, a New Jersey laboratory facility in Curia, was acquired by Pace Analytical Services. The acquisition will offer support to drug development partners that are new in the market by providing rapid and highly expert development and analytical laboratory services on a commercial basis across the biopharma sector.

In November of 2024, Altasciences stated that it has expanded its bioanalytical service portfolio by providing flexible, high-quality analytical solutions for preclinical and clinical studies, reinforcing its 30-year commitment to accelerating global drug development and client success.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Charles River Laboratories International
  • Syneos Health
  • SGS SA
  • WuXi AppTec
  • Thermo Fisher Scientific Inc (PPD, Inc.)
  • Parexel International
  • Pharmaron
  • BioAgilytix Labs
  • KCAS Bio
  • ICON plc
  • Labcorp
  • Eurofins Scientific SE
  • QPS Holdings
  • Altasciences
  • Others

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032

  • Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Spectroscopic Techniques
  • Genomic and Molecular Techniques
  • Method Development and Validation
  • Sample Collection and Preparation
  • Sample Collection, Handling and Storage
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
  • Others
  • Other processes

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032

  • Small Molecule
  • Large Molecule

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032

  • Bioavailability
  • Bioequivalence
  • Biomarker Testing
  • ADME
  • In-vivo
  • In-vitro
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Cell-based Assay
  • Virology Testing
  • Other Tests

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • CDMO
  • CRO
  • Pharma & BioPharma Companies
  • Others

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical Bioanalytical Testing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical Bioanalytical Testing Services Market Snippet by Workflow
    • 2.1.2. Preclinical Bioanalytical Testing Services Market Snippet by Molecule
    • 2.1.3. Preclinical Bioanalytical Testing Services Market Snippet by Test
    • 2.1.4. Preclinical Bioanalytical Testing Services Market Snippet by End Use
    • 2.1.5. Preclinical Bioanalytical Testing Services Market Snippet by Country
    • 2.1.6. Preclinical Bioanalytical Testing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical Bioanalytical Testing Services Key Market Trends

  • 3.1. Preclinical Bioanalytical Testing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical Bioanalytical Testing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical Bioanalytical Testing Services Market Opportunities
  • 3.4. Preclinical Bioanalytical Testing Services Market Future Trends

4. Preclinical Bioanalytical Testing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preclinical Bioanalytical Testing Services Market Landscape

  • 6.1. Preclinical Bioanalytical Testing Services Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical Bioanalytical Testing Services Market - By Workflow

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow, 2024 & 2032 (%)
    • 7.1.2. Sample Analysis
      • 7.1.2.1. Hyphenated technique
      • 7.1.2.2. Chromatographic technique
      • 7.1.2.3. Electrophoresis
      • 7.1.2.4. Ligand Binding Assay
      • 7.1.2.5. Mass Spectrometry
      • 7.1.2.6. Spectroscopic Techniques
      • 7.1.2.7. Genomic and Molecular Techniques
    • 7.1.3. Method Development and Validation
    • 7.1.4. Sample Collection and Preparation
      • 7.1.4.1. Sample Collection, Handling and Storage
      • 7.1.4.2. Protein Precipitation
      • 7.1.4.3. Liquid-Liquid Extraction
      • 7.1.4.4. Solid Phase Extraction
      • 7.1.4.5. Others
    • 7.1.5. Other processes

8. Preclinical Bioanalytical Testing Services Market - By Molecule

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
    • 8.1.2. Small Molecule
    • 8.1.3. Large Molecule

9. Preclinical Bioanalytical Testing Services Market - By Test

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
    • 9.1.2. Bioavailability
    • 9.1.3. Bioequivalence
    • 9.1.4. Biomarker Testing
    • 9.1.5. ADME
      • 9.1.5.1. In-vivo
      • 9.1.5.2. In-vitro
    • 9.1.6. Pharmacokinetics (PK)
    • 9.1.7. Pharmacodynamics (PD)
    • 9.1.8. Cell-based Assay
    • 9.1.9. Virology Testing
    • 9.1.10. Other Tests

10. Preclinical Bioanalytical Testing Services Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
    • 10.1.2. CDMO
    • 10.1.3. CRO
    • 10.1.4. Pharma & BioPharma Companies
    • 10.1.5. Others

11. Preclinical Bioanalytical Testing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preclinical Bioanalytical Testing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Preclinical Bioanalytical Testing Services Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Charles River Laboratories International
    • 12.2.2. Syneos Health
    • 12.2.3. SGS SA
    • 12.2.4. WuXi AppTec
    • 12.2.5. Thermo Fisher Scientific Inc (PPD, Inc.)
    • 12.2.6. Parexel International
    • 12.2.7. Pharmaron
    • 12.2.8. BioAgilytix Labs
    • 12.2.9. KCAS Bio
    • 12.2.10. ICON plc
    • 12.2.11. Labcorp
    • 12.2.12. Eurofins Scientific SE
    • 12.2.13. QPS Holdings
    • 12.2.14. Altasciences
    • 12.2.15. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us